+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Investigation Report on China's Atorvastatin Market 2021-2025

  • PDF Icon

    Report

  • 50 Pages
  • July 2021
  • Region: China
  • China Research & Intelligence
  • ID: 5312017
Atorvastatin is a statin drug, which is used to lower blood cholesterol levels. This common drug is mainly used to treat high cholesterol, hyperlipidemia, and coronary heart disease. The original drug Atorvastatin was developed by Pfizer Pharmaceuticals under the trade name LIPITOR. According to the analysis, Lipitor entered the Chinese market in 1999, and then some Chinese local companies' generic drugs were successively listed. Pfizer Pharmaceuticals still accounts for the most market share in China by 2020.

According to the analyst's market research, the sales value of Atorvastatin in the Chinese market increased from 2016 to 2018. In 2019, due to being included in the Chinese government's "4+7" policy for drug centralized procurement, the price of the drug fell sharply, resulting in a year-on-year decrease of 18.33% in its sales value. In 2020, due to the impact of COVID-19 on the overall diagnosis and treatment services of the hospital, the sales value of Atorvastatin in the Chinese market in 2020 dropped to CNY825 million, and the CAGR is about -20.30% from 2016 to 2020.

The analyst expects that with the effective relief of COVID-19, the sales value of Atorvastatin in the Chinese market will have a restorative growth from 2021 to 2025. In addition, the seventh census showed that as of the end of 2020, the total population of China was 1,411.78 million, and the population of 60 years and over was 264.02 million, accounting for 18.70% of the total population. It is expected that the elderly population in China will show an increasing trend. The proportion of the elderly population will continue to rise, and the incidence of cardiovascular diseases will continue to rise accordingly. In addition, as the pace of life of Chinese residents accelerates, unhealthy lifestyles increase the risk of blood lipid diseases and expand the market for Atorvastatin. Therefore, The analyst predicts that sales value of Atorvastatin in the Chinese market will continue to grow from 2021 to 2025.

Table of Contents

1 Relevant Concepts of Atorvastatin
1.1 Indications for Atorvastatin
1.2 Development of Atorvastatin in China
1.3 Governmental Approval of Atorvastatin in China
1.4 The Impact of COVID-19 on Atorvastatin sales in China
2 Sales of Atorvastatin in China, 2016-2020
2.1 Sales Value of Atorvastatin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Regions
2.2 Sales Volume of Atorvastatin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 Sales of Atorvastatin by Dosage Form in China, 2016-2020
2.3.1 Dispersible Tablets
2.3.3 Tablets
2.3.3 Capsules
3 Analysis of Major Atorvastatin Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Atorvastatin Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Pfizer Inc
3.2.1 Enterprise Profile
3.2.2 Sales of LIPITOR (Pfizer Inc’s Atorvastatin) in China
3.3 Lepu Medical Technology Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Youliping (Lepu Medical Technology Co., Ltd.’s Atorvastatin) in China
3.4 Beijing Jialin Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Ale (Beijing Jialin Pharmaceutical Co., Ltd.’s Atorvastatin) in China
3.5 Qilu Pharmaceutical (Hainan) Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Meidaxin (Qilu Pharmaceutical (Hainan) Co., Ltd.’s Atorvastatin) in China
3.6 Fujian Dawnrays Pharmaceutical Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Anweining (Fujian Dawnrays Pharmaceutical Co., Ltd.’s Atorvastatin) in China
4 Prices of Atorvastatin for Different Manufacturers in China, 2020-2021
4.1 Pfizer Inc (LIPITOR)
4.2 Lepu Medical Technology Co., Ltd. (Youliping)
4.3 Beijing Jialin Pharmaceutical Co., Ltd. (Ale)
4.4 Qilu Pharmaceutical (Hainan) Co., Ltd. (Meidaxin)
4.5 Fujian Dawnrays Pharmaceutical Co., Ltd. (Anweining)
5 Prospect of Chinese Atorvastatin Market, 2021-2025
5.1 Influential Factors of Chinese Atorvastatin Market Development
5.1.1 The Impact of COVID-19 on Chinese Atorvastatin Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Atorvastatin Dispersible Tablets Registration in China
Chart Patent Information About Atorvastatin Tablets Registration in China
Chart Patent Information About Atorvastatin Capsules Registration in China
Chart Sales Value of Atorvastatin Dispersible Tablets over the World
Chart Sales Value of Atorvastatin Tablets over the World
Chart Sales Value of Atorvastatin Capsules over the World
Chart Sales Value of Atorvastatin Dispersible Tablets in China, 2016-2020
Chart Sales Value of Atorvastatin Tablets in China, 2016-2020
Chart Sales Value of Atorvastatin Capsules in China, 2016-2020
Chart Sales Value of Atorvastatin Dispersible Tablets in China by Regions, 2016-2020
Chart Sales Value of Atorvastatin Tablets in China by Regions, 2016-2020
Chart Sales Value of Atorvastatin Capsules in China by Regions, 2016-2020
Chart Sales Volume of Atorvastatin Dispersible Tablets in China, 2016-2020
Chart Sales Volume of Atorvastatin Tablets in China, 2016-2020
Chart Sales Volume of Atorvastatin Capsules in China, 2016-2020
Chart Sales Volume of Atorvastatin Dispersible Tablets in China by Regions, 2016-2020
Chart Sales Volume of Atorvastatin Tablets in China by Regions, 2016-2020
Chart Sales Volume of Atorvastatin Capsules in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Atorvastatin Dispersible Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Atorvastatin Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Atorvastatin Capsules Manufacturers in China, 2016-2020
Chart Sales Value and Volume of LIPITOR in China, 2016-2020
Chart Sales Value and Volume of Youliping in China, 2016-2020
Chart Sales Value and Volume of Ale in China, 2016-2020
Chart Sales Value and Volume of Meidaxin in China, 2016-2020
Chart Sales Value and Volume of Anweining in China, 2016-2020
Chart Referential Prices of LIPITOR in China by Regions, 2020-2021
Chart Referential Prices of Youliping in China by Regions, 2020-2021
Chart Referential Prices of Ale in China by Regions, 2020-2021
Chart Referential Prices of Meidaxin in China by Regions, 2020-2021
Chart Referential Prices of Anweining in China by Regions, 2020-2021
Chart Forecast on Sales Value of Atorvastatin Dispersible Tablets in China, 2021-2025
Chart Forecast on Sales Value of Atorvastatin Tablets in China, 2021-2025
Chart Forecast on Sales Value of Atorvastatin Capsules in China, 2021-2025
Chart Forecast on Sales Volume of Atorvastatin Dispersible Tablets in China, 2021-2025
Chart Forecast on Sales Volume of Atorvastatin Tablets in China, 2021-2025
Chart Forecast on Sales Volume of Atorvastatin Capsules in China, 2021-2025

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc (LIPITOR)
  • Lepu Medical Technology Co., Ltd. (Youliping)
  • Beijing Jialin Pharmaceutical Co., Ltd. (Ale)
  • Qilu Pharmaceutical (Hainan) Co., Ltd. (Meidaxin)
  • Fujian Dawnrays Pharmaceutical Co., Ltd. (Anweining)

Methodology

Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.

Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.

Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.

The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.

The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.

1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.


 

Loading
LOADING...